Thursday, March 25, 2021 11:17:59 PM
I have been here for many many years and know firsthand the local area where mine is located.
I would like to hear more specific information from the company in a form of a press release indicating which specific exchange they are discussing and also what exchange will spin off be on as well plus if we’re getting shares in a potential spin off - how many are we getting. I ALSO would like to know including if there is ANY reverse spilt in their plans to achieve that $1.00 minimum stock price to qualify. If not - what’s their plans release PR’s to boost and capture attention and market interest? I feel like while it is appreciated they discussed in a PR- however it would be ideal if they provided a clearer understanding to shareholders. If they are doing a reverse split or If they choose to stay quiet on that - then after being a long time shareholder —I’ll likely sell off. I’m watching very closely. If it looks their going down that road with a RS- I’m out.
I do not want to see dilution either that will hurt shareholders so I’m very keen on seeing how they go about securing financing as well and any term sheet they sign. Reverse splits usually have a tendency to fall after they occur, usually like the Titanic. I’ll move to protect my own investment capital if that occurs, by jettisoning it.
Today the PPS showed a little weakness and we’ll see if it declines back down to .20’s - this company usually IMO doesn’t move too fast, so hard to tell how long this will all take. Right now in the .30’s I’m possibly selling some off take some profit. I saw the options sold as well that were set up and filed.
I am up as well - double +.
Recent IDR News
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:35:07 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/28/2023 05:15:07 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 11:21:42 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2023 08:26:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2023 11:31:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 07:49:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 05:16:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 10:32:27 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2023 06:49:48 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM